A

AgenT

120 employees

AgenT develops the first blood diagnosis to detect Alzheimer's disease from the asymptomatic stage.

Basic info

Industry

biotechnology research

Sectors

Health Diagnostics
Biotechnology
Neuroscience
Health Care
Machine learning
AI
Diagnosis
ALzheimer's disease
Life Science

Date founded

2018

Funding rounds raised

A

AgenT raised undisclosed on January 1, 2021

Investors: Creative Destruction Lab

FAQ